3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins,

Details 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins,

1988-01-21

1989-04-18

Lee, Mary C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514436, 549 14, 549 20, A61K 31385, A61K 3139, C07D32706, C07D33908

Patent

active

048228133

ABSTRACT:
Novel 3-(2-haloalkyl)-1,4-oxathiins or 2-(2-haloalkyl)-1,4-dithiins, useful for regressing or inhibiting the growth of leukemia and tumors in mammals. The compounds have the formula.: ##STR1## wherein R.sub.1 is an alkyl group containing up to 4 carbon atoms, cyclohexyl or phenyl;

REFERENCES:
patent: 3868459 (1975-02-01), Esclamadon
patent: 3882237 (1975-05-01), Knight et al.
patent: 4319003 (1982-03-01), Tsai et al.

Affiliated with

Also associated with

Rating

3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2397221